Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence.
Publications on programmed cell death in uveal melanoma grew 11.05% annually, 1999-2024.
Charting the growth of programmed cell death studies in uveal melanoma: a bibliometric evidence.
Uveal melanoma is a malignant intraocular tumor with a high propensity for metastasis, and the significance of programmed cell death (programmed cell death) in this disease has attracted growing attention in recent decades.
Data were collected from the Web of Science Core Collection (Web of Science Core Collection) for publications dated January 1, 1999-December 31, 2024.
The United States and China emerged as the leading producers of relevant publications, exhibiting robust and often international collaborative networks.
This bibliometric study established a view of programmed cell death research trends in uveal melanoma, demonstrating the field's rapid expansion, strong international collaborations, and an increasing emphasis on emerging cell-death pathways.
These results underscore that deeper mechanistic insights into programmed cell death processes have the potential to inform more effective therapies and prognostic tools, particularly in light of the limited treatment options once metastatic disease occurs.